FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...